Buy, Sell, or Hold | Stock Market Video

The stock charts used in this presentation are provided by WONDA ® Copyright © 2015 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

In this week's Stock Market Video, Cabot China & Emerging Markets Report Editor Paul Goodwin points out that although the market is jumpy, it has rebounded nicely from its three-day swan dive that began on February 21. Still, different stocks have reacted very differently to both the correction and the bounce, and knowing how to interpret the charts can help you make those all-important buy, sell and hold decisions. Stocks discussed include: First Solar (FSLR), Credit Suisse (CS), Ocwen Financial (OCN), Medicines Company (MDCO), Popular (BPOP) and NXP Semiconductors (NXPI).


Double Your Money with Cabot China & Emerging Markets Report

Dear Fellow Investor,

When I'm talking to people about investing in emerging market stocks, I'm always aware that I have two choices. The first is to spout statistics:

*    About China's 1.3 billion people
*    The build-out of Internet access
*    The rising power of the Chinese consumer
*    The country's decade of double-digit economic growth
*    Colossal investment in infrastructure.

There's no doubt that these are impressive factors, and they certainly point to a national economy that's in high gear. But I don't think they tell the whole story.

If a growing economy automatically produced stock market gains, an investor's job would be very simple. You could just buy an ETF for that country and watch the money roll in.

But stock markets are too complex to reward that strategy, as investors are always looking ahead by six months or so. And just drawing a straight line that extends the current trend is almost sure to miss the mark.

As the emerging markets develop, their economies often rocket ahead, lifted by industrialization, urbanization, entrepreneurship and foreign direct investment. 

And the stocks of the companies doing business in these countries can blast off right along with them. This is what investors in Baidu (BIDU), China Mobile (CHL) and (CTRP) found out a few years ago.

That's when Cabot China & Emerging Markets Report beat all investment advisories hands-down, doubling readers' retirement money four times in seven years.  

Just last year:…

Our top auto stock was up 127% in four months.
Our top entertainment stock was up 113% in 10 months.
Our top Internet stock was up 106% in six months.
Our top social networking stock was up 115% in five months.

And our China stocks continue to out perform the market!

Our instant messaging stock is up 25% in three months.
Our Amazon-like online retail stock is up 36% in three months.
Our flash sale online retail stock is up 35% in two months.
Our online games stock is up 23% in one month.

All while our entire portfolio is up 42% since the beginning of the year!

So don't wait. Click here to learn more on how Cabot China & Emerging Markets Report picks can be a great addition to your portfolio. Get your risk-free trial subscription today.

Order Now Learn More


Paul Goodwin Signature

Paul Goodwin

Editor, Cabot China & Emerging Markets Report

Paul Goodwin Paul Goodwin 
Emerging Markets Specialist, Analyst and Editor of Cabot China & Emerging Markets Report

A researcher and writer for over 30 years, Paul Goodwin has been a member of the Cabot investment team and editor of Cabot China & Emerging Markets Report since 2005. Under Paul’s stewardship, Hulbert Financial Digest rated Cabot China & Emerging Markets Report the #1-rated newsletter of 2006 with a 78.6% gain for the year, and the #1-rated newsletter of 2007 with a  74.1% return. Cabot China & Emerging Markets Report was also named 2007 Investment Letter of the Year by Peter Brimelow of MarketWatch

Stock Picks


The fact that these stocks couldn’t rally even in the market strength of the past month tells us there’s little hope for the rest of the year.

Newfield Exploration

This oil & gas producer looks like an early leader.

Mindray Medical

Mindray has made a global name for itself, designing and refining medical equipment that can be sold more cheaply than the big international brands.

Cabot Wealth Advisory

Three Things I'm Thankful For

By Paul Goodwin on November 25, 2015

The question of thankfulness is especially interesting to me because I write a financial advisory on how to invest in emerging market stocks, and I know that being a growth investor requires a certain amount of optimism. Pessimists don’t buy growth stocks because they believe deeply that most things will turn out badly. With all that philosophical maundering out of the way, I’d like to run down my optimistic list of things I’m thankful for.Read More >

Yes, You Can Have Both Dividends and Growth

By Timothy Lutts on November 24, 2015

How do you find growth companies that pay dividends? Using the Cabot resources, there are two excellent ways. One is to refer to Cabot Dividend Investor, which recommends three specific classes of stocks for its readers: High Yield, Dividend Growth and Safe Income.Read More >

Two Stocks Mr. Buffett Should Own

By J. Royden Ward on November 23, 2015

As Warren Buffett said, "Long ago, Ben Graham taught me that ‘Price is what you pay; value is what you get.’ Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.” Two stocks that I think Mr. Buffett should own are Johnson Controls and Whirlpool. Read More >